Stock Market News

Corcept's ovarian cancer drug cuts disease progression in study, shares jump

Mar 31, 2025 - 18:54
 0
Corcept's ovarian cancer drug cuts disease progression in study, shares jump
Read More

Tags:

Previous Article

Ready to Retire? 3 Must-Know Questions You Can’t Afford to Skip

Next Article

Empro Group Files for 1.25M Share IPO at $4-$4.50/sh

Related Posts

China Vanke's 'B-' ratings put on credit watch due to management changes: S&P Global

China Vanke's 'B-' ratings put on credit watch due to m...

Mar 5, 2025  0

Goldman Sachs managing director Scott Rubner leaves firm, source says

Goldman Sachs managing director Scott Rubner leaves fir...

Mar 10, 2025  0

Scale AI seeking valuation as high as $25 billion in potential tender offer, Business Insider reports

Scale AI seeking valuation as high as $25 billion in po...

Mar 28, 2025  0